C

Cognetivity Neurosciences Ltd
CNSX:CGN

Watchlist Manager
Cognetivity Neurosciences Ltd
CNSX:CGN
Watchlist
Price: 0.01 CAD Market Closed
Market Cap: CA$885.9k

Operating Margin

-4 474%
Current
Improving
by 5 008.1%
vs 3-y average of -9 482.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 474%
=
Operating Income
CA$-4.4m
/
Revenue
CA$99k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 474%
=
Operating Income
CA$-4.4m
/
Revenue
CA$99k

Peer Comparison

Country Company Market Cap Operating
Margin
CA
Cognetivity Neurosciences Ltd
CNSX:CGN
895.6k CAD
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
US
Gartner Inc
NYSE:IT
17.1B USD
Loading...
IE
ICON PLC
NASDAQ:ICLR
14.1B USD
Loading...
US
Ionis Pharmaceuticals Inc
NASDAQ:IONS
12.8B USD
Loading...
US
Charles River Laboratories International Inc
NYSE:CRL
10.7B USD
Loading...
US
Halozyme Therapeutics Inc
NASDAQ:HALO
8.2B USD
Loading...
US
Cytokinetics Inc
NASDAQ:CYTK
7.9B USD
Loading...
UK
Verona Pharma PLC
NASDAQ:VRNA
7.4B USD
Loading...

Market Distribution

Lower than 95% of companies in Canada
Percentile
5th
Based on 4 855 companies
5th percentile
-4 474%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

Cognetivity Neurosciences Ltd
Glance View

Market Cap
885.9k CAD
Industry
N/A

Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-03-19. The firm is engaged in developing a cognitive testing platform, the integrated cognitive assessment (ICA), for use in medical and commercial environments for allowing early diagnosis of dementia. The Company’s ICA uses artificial intelligence and machine learning techniques to detect the earliest signs of cognitive impairment by testing the performance of brain. Its products include CognICA and OptiMind. The CognICA has various applications from early detection of cognitive impairment in dementia and multiple sclerosis (MS), to long-term health monitoring, corporate wellness, and personalized brain health. The OptiMind is a wellness app that measures individuals everyday cognitive performance. The firm serves various industries, including healthcare, elder care, enterprise, everyday use, and research. The ICA is available for clinical use in the United States of America, United Kingdom and Europe.

CGN Intrinsic Value
Not Available
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-4 474%
=
Operating Income
CA$-4.4m
/
Revenue
CA$99k
What is Cognetivity Neurosciences Ltd's current Operating Margin?

The current Operating Margin for Cognetivity Neurosciences Ltd is -4 474%, which is above its 3-year median of -9 482.1%.

How has Operating Margin changed over time?

Over the last 10 months, Cognetivity Neurosciences Ltd’s Operating Margin has increased from -13 868.7% to -4 474%. During this period, it reached a low of -13 868.7% on Jan 31, 2023 and a high of -4 474% on Dec 1, 2023.

Back to Top